Safety and efficacy of magnetic sphincter augmentation dilation
- 1 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 35 (7), 3861-3864
- https://doi.org/10.1007/s00464-020-07799-8
Abstract
Background The magnetic sphincter augmentation device (MSA) provides effective relief of gastroesophageal reflux symptoms. Dysphagia after MSA implantation sometimes prompts endoscopic dilation. The manufacturer's instructions are that it be performed 6 or more weeks after implantation under fluoroscopic guidance to not more than 15 mm keeping 3 or more beads closed. The purpose of this study was to assess adherence to these recommendations and explore the techniques used and outcomes after MSA dilation. Methods and procedures We conducted a multicenter retrospective review of patients undergoing dilation for dysphagia after MSA placement from 2012 to 2018. Results A total of 144 patients underwent 245 dilations. The median size of MSA placed was 14 beads (range 12-17) and the median time to dilation was 175 days. A second dilation was performed in 67 patients, 22 patients had a third dilation and 7 patients underwent 4 or more dilations. In total, 17 devices (11.8%) were eventually explanted. The majority of dilations were performed with a balloon dilator (81%). The median dilator size was 18 mm and 73.4% were done with a dilator larger than 15 mm. There was no association between dilator size and need for subsequent dilation. Fluoroscopy was used in 28% of cases. There were no perforations or device erosions related to dilation. Discussion There is no clinical credence to the manufacturer's recommendation for the use of fluoroscopy and limitation to 15 mm when dilating a patient for dysphagia after MSA implantation. Use of a larger size dilator was not associated with perforation or device erosion, but also did not reduce the need for repeat dilation. Given this, we would recommend that the initial dilation for any size MSA device be done using a 15 mm through-the-scope balloon dilator. Dysphagia prompting dilation after MSA implantation is associated with nearly a 12% risk of device explantation.This publication has 11 references indexed in Scilit:
- Clinical Outcomes and Predictors of Favorable Result after Laparoscopic Magnetic Sphincter Augmentation: Single -Institution Experience with More than 500 Patients ? Check for updatesJournal of the American College of Surgeons, 2020
- Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and ManagementJournal of Gastrointestinal Surgery, 2019
- Objective Evidence of Reflux Control After Magnetic Sphincter AugmentationAnnals of Surgery, 2019
- Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trialGastrointestinal Endoscopy, 2018
- Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux diseaseSurgical Endoscopy, 2018
- Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentationSurgical Endoscopy, 2017
- Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 PatientsJournal of the American College of Surgeons, 2015
- Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal RefluxClinical Gastroenterology and Hepatology, 2015
- Short-Term Outcomes Using Magnetic Sphincter Augmentation Versus Nissen Fundoplication for Medically Resistant Gastroesophageal Reflux DiseaseThe Annals of Thoracic Surgery, 2014
- Reflux and Belching After 270 Degree Versus 360 Degree Laparoscopic Posterior FundoplicationAnnals of Surgery, 2012